40. 高安動脈炎 Takayasu arteritis Clinical trials / Disease details


臨床試験数 : 25 薬物数 : 50 - (DrugBank : 21) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 114

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03550781
(ClinicalTrials.gov)
June 1, 20185/5/2018Anti-inflammatory Treatment for Inactive Takayasu ArteritisDoes Inactive Takayasu Arteritis(NIH Criteria) Need Anti-inflammatory Treatment?Takayasu Arteritis;Anti-Inflammatory AgentsDrug: Prednisone, cyclophosphamideChinese Academy of Medical Sciences, Fuwai HospitalNULLNot yet recruiting10 Years40 YearsAll40Phase 2/Phase 3NULL
2NCT02981979
(ClinicalTrials.gov)
December 201622/11/2016Takayasu Arteritis Clinical Trial in ChinaComparison of the Efficacy and Safety of Leflunomide Versus Placebo Combine With the Basic Prednisone Therapy in Patients With Active Phase of Takayasu's Arteritis: a Randomized Controlled Double-blinded TrialTakayasu ArteritisDrug: Leflunomide 10mg Tab;Drug: Prednisone Acetate;Drug: PlacebosJiang lindiNULLUnknown status18 Years65 YearsAll116N/AChina
3NCT00006055
(ClinicalTrials.gov)
March 20005/7/2000Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune DiseasesPurpura, Schoenlein-Henoch;Graft Versus Host Disease;Anemia, Hemolytic, Autoimmune;Rheumatoid Arthritis;Churg-Strauss Syndrome;Hypersensitivity Vasculitis;Wegener's Granulomatosis;Systemic Lupus Erythematosus;Giant Cell Arteritis;Pure Red Cell Aplasia;Juvenile Rheumatoid Arthritis;Polyarteritis Nodosa;Autoimmune Thrombocytopenic Purpura;Takayasu ArteritisDrug: anti-thymocyte globulin;Drug: cyclophosphamide;Drug: cyclosporine;Drug: filgrastim;Drug: methylprednisolone;Drug: prednisone;Procedure: Autologous Peripheral Blood Stem Cell TransplantationFairview University Medical CenterNULLActive, not recruiting1 Year55 YearsBoth10N/AUnited States